Medical Equipment

NGS-Based RNA-Sequencing Market Analysis Through 2030 Focusing On Demand Trends And Growth Drivers

May 15, 2026May 19, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

By 2030, How Much Growth In Market Size Is Expected For The NGS-Based RNA-Sequencing Market?

The ngs-based rna-sequencing market size has experienced significant expansion in recent years. It is anticipated to increase from $4.2 billion in 2025 to $5.27 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 25.3%. The growth observed in prior periods can be attributed to the broadening of genomic research initiatives, a reduction in the cost of sequencing technologies, expanded utilization of rna-seq in academic research, the accessibility of advanced sequencing platforms, and the development of bioinformatics capabilities.

The ngs-based rna-sequencing market is projected for rapid expansion in the coming years. This market is anticipated to reach a valuation of $12.73 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 24.7%. Drivers for this growth during the projected timeframe include the expanding use of RNA sequencing in clinical diagnostics, increased funding for precision medicine, the broadening scope of pharmaceutical research applications, a rising need for integrated data analysis tools, and a heightened emphasis on multi-omics research. Key trends expected within this period involve the greater uptake of high-throughput RNA sequencing platforms, increasing interest in single-cell RNA sequencing, wider utilization of cloud-based bioinformatics analysis, the integration of transcriptomics into precision medicine, and a stronger focus on data precision and scalability.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7416&type=smp

What Key Growth Drivers Are Influencing The NGS-Based RNA-Sequencing Market?

The expanding pharmaceutical sector is anticipated to boost the future growth of the NGS-based RNA-sequencing market. This industry encompasses the discovery, development, and production of drugs and medicines by both governmental and private entities. The pharmaceutical industry utilizes NGS-based RNA-sequencing for comprehensive analysis of gene expression, identification of potential drug targets, assessment of drug responses, and understanding disease mechanisms, thereby facilitating drug discovery and development through a deeper understanding of molecular processes. For instance, in June 2025, according to the Centers for Medicare & Medicaid Services (CMS), a US-based federal agency, prescription drug outlays increased by 11.4% in 2023, reaching $449.7 billion, which was an acceleration from the 7.8% growth recorded in 2022. Therefore, the burgeoning pharmaceutical industry is propelling the growth of the NGS-based RNA-sequencing market.

How Is The NGS-Based RNA-Sequencing Market Examined Through Segment Analysis?

The ngs-based rna-sequencing market covered in this report is segmented –

1) By Product And Service: Sample Preparation Products, Sequencing Platforms and Consumables, Sequencing Services, Data Analysis, Storage, and Management

2) By Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing

3) By Application: Expression Profiling Analysis, Small RNA Sequencing, De Novo Transcriptome Assembly

4) By End User: Research & Academia, Pharmaceutical & Biotechnology Companies, Other End Users

Subsegments:

1) By Sample Preparation Products: RNA Extraction Kits, Library Preparation Kits, Reverse Transcription Kits, Quality Control Reagents

2) By Sequencing Platforms And Consumables: Sequencing Instruments, Sequencing Consumables

3) By Sequencing Services: Contract Sequencing Services, Custom Library Preparation Services, Consultation And Experimental Design Services

4) By Data Analysis, Storage, And Management: Bioinformatics Software, Data Analysis Services, Cloud-Based Data Storage Solutions, Data Management Platforms

Which Trends Are Supporting The Evolution Of The NGS-Based RNA-Sequencing Market?

Companies prominent in the NGS-based RNA-sequencing market are prioritizing the creation of novel offerings, specifically sophisticated small RNA-seq kits, to optimize workflows and enhance the precision and effectiveness of RNA expression analysis. These advanced kits represent next-generation library preparation instruments crafted for precise capture and sequencing of small RNAs, enabling researchers to shorten workflow durations, mitigate artifacts like adapter dimers, and attain more accurate and consistent expression profiling. As an example, in October 2025, the Austrian biotechnology firm Lexogen introduced its miRVEL Profiling Small RNA-Seq Library Prep Kit, which aims to simplify and refine small RNA research processes. This groundbreaking kit offers a quicker and more dependable workflow, allowing the preparation of libraries ready for sequencing in less than seven hours, requiring minimal manual input. Key features include cutting-edge adapter blocking technology to inhibit adapter dimer formation, guaranteeing consistent outcomes across different input quantities, and integrated 8 nt unique dual indices (UDIs) for precise multiplexing and read assignment. The miRVEL Profiling Kit accommodates diverse applications, such as RNA interference investigations, host-defense mechanism examinations, and small RNA research in plant or agricultural contexts. Furthermore, it is compatible with Lexogen’s SPLIT RNA extraction kits and TraPR small RNA enrichment system, thereby offering a comprehensive, end-to-end solution for small RNA analysis.

Which Companies Are Influencing The NGS-Based RNA-Sequencing Market?

Major companies operating in the ngs-based rna-sequencing market are Illumina Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies Ltd., Agilent Technologies Inc., BGI Group, QIAGEN N.V., Eurofins Scientific SE, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Takara Bio Inc., GENEWIZ Inc., Novogene Corporation, Macrogen Inc., Zymo Research Corp., Lexogen GmbH, Partek Incorporated, GATC Biotech AG, Genohub LLC, BaseClear B.V., Otogenetics Corporation, SeqLL LLC, GenXPro GmbH, Genotypic Technology Pvt. Ltd.

Access The Complete NGS-Based RNA-Sequencing Market Report:

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

Which Region Stands As The Largest Contributor To The NGS-Based RNA-Sequencing Market?

North America was the largest region in the NGS-based RNA sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ngs-based rna-sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a NGS-Based RNA-Sequencing Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

Browse Through More Reports Similar to the Global NGS-Based RNA-Sequencing Market 2026, By The Business Research Company

Clinical Next Generation Sequencing Ngs Data Analysis Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-next-generation-sequencing-ngs-data-analysis-global-market-report

Rna Sequencing Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/rna-sequencing-services-global-market-report

Next Generation Sequencing Market 2026

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795